Cyclophosphamide cardiotoxicity in bone marrow transplantation: a prospective evaluation of new dosing regimens
about
Acute Cyclophosphamide Hemorrhagic Myopericarditis: Dilemma Case Report, Literature Review and Proposed Diagnostic CriteriaGetting to the Heart of the Matter: An Overview of Cardiac Toxicity Related to Cancer TherapyRecent Advances on Pathophysiology, Diagnostic and Therapeutic Insights in Cardiac Dysfunction Induced by Antineoplastic DrugsExpert consensus for multimodality imaging evaluation of adult patients during and after cancer therapy: a report from the American Society of Echocardiography and the European Association of Cardiovascular Imaging.Outcome of allogeneic hematopoietic stem cell transplantation in patients with low left ventricular ejection fraction.Noninvasive diagnosis of chemotherapy related cardiotoxicityCancer therapy and cardiotoxicity: the need of serial Doppler echocardiography.Cardiotoxicity of cancer therapy.Long-term consequences of hematopoietic stem cell transplantation: current state of the science.Predictors of late cardiovascular complications in survivors of hematopoietic cell transplantation.Use of paclitaxel in patients with pre-existing cardiomyopathy: a review of our experience.Malignant pericardial effusion.Emergent Complications in the Pediatric Hematopoietic Stem Cell Transplant PatientNon-endocrine late complications of bone marrow transplantation in childhood: part I.Early identification of anthracycline cardiomyopathy: possibilities and implications.Changes in echocardiographic measures of systolic and diastolic function in children 1 year after hematopoietic SCTEarly left ventricular dysfunction in children after hematopoietic stem cell transplantation for acute leukemia: a case control study using speckle tracking echocardiography.Electrocardiographic and cardiovascular effects of the 5-hydroxytryptamine3 receptor antagonists.Incidence and predictors of congestive heart failure after autologous hematopoietic cell transplantation.Mechanisms of Fatal Cardiotoxicity following High-Dose Cyclophosphamide Therapy and a Method for Its PreventionHematopoietic stem cell transplantation in patients with systolic dysfunction: can it be done?Cyclophosphamide-Induced Cardiomyopathy: A Case Report, Review, and Recommendations for Management.Cardiac toxicity of high-dose chemotherapy.Cardiotoxicity from intensive chemotherapy combined with radiotherapy in breast cancerBone marrow transplantation may augment cardiac systolic function in patients with a reduced left ventricular ejection fractionCancer Therapy-Related Cardiac Dysfunction and Heart Failure: Part 1: Definitions, Pathophysiology, Risk Factors, and Imaging.Subclinical cardiotoxicity following adjuvant dose-escalated FEC, high-dose chemotherapy, or CMF in breast cancer.Effect of bone marrow transplantation on diastolic function indices.Treatment of relapsing-remitting multiple sclerosis with high-dose cyclophosphamide induction followed by glatiramer acetate maintenance.Long term follow-up report of cardiac toxicity in patients with multiple myeloma treated with tandem autologous hematopoietic stem cell transplantation.Post-transplant bendamustine reduces GvHD while preserving GvL in experimental haploidentical bone marrow transplantation.Late congestive heart failure after hematopoietic cell transplantationCardiac complications in patients undergoing a reduced-intensity conditioning hematopoietic stem cell transplantationCardiovascular disease in survivors of hematopoietic cell transplantation.Biological drugs: classic adverse effects and new clinical evidences.Cancer drugs and the heart: importance and management.5-Hydroxytryptamine3 receptor antagonists and cardiac side effects.Tyrosine kinase-targeting drugs-associated heart failure.Update on cardiotoxicity of anti-cancer treatments.Cardiomyopathy in patients after posttransplant cyclophosphamide-based hematopoietic cell transplantation.
P2860
Q26775467-2C3CBE62-0C30-44D7-B47F-B0DB409157D2Q26797138-8166AEFF-FEF7-4AF9-BA6B-DDE135258E8CQ28087776-83FCD2FF-98C2-425F-B645-039FF2040BABQ30401812-20CFF2FD-9B94-46C4-8719-D84B1C66A41AQ30434110-03CDDE75-DE01-4745-B698-209B758CBA25Q30461444-EE50D7D6-F690-4EDD-B26A-BC97404BD573Q30500830-265D8D6F-1C5E-45F7-88A3-9FC1E8D5F5F9Q33704056-DAAE9B41-EFFD-48AF-A11D-7872B93D2E7EQ33705877-EEBF6FC2-8844-4591-B7DA-F1837346D8E4Q33926274-EBEC34F6-62BF-4971-B775-2A069ED8BD2DQ34273153-73FDDC90-FB2D-49E5-85A9-164384B53D80Q34338215-546C7818-BE32-45BC-A4F4-0986D3985AAEQ34522746-DADB64AB-4A5B-4592-9E34-367A66F69ADFQ34722697-AD492EF3-07B4-4BA7-B75F-AF160170AE9DQ34800157-B7B12EAD-7159-47B7-A019-2E9D036976CAQ35019395-98F90736-8D7C-4B07-A2B0-BC33D4C5553FQ35028620-A86DBD25-D701-4322-BF4E-D55547CE72A6Q35201044-3445DB21-C795-4E1F-B0FD-86C82ED22F2AQ35604039-92B59654-CB75-4190-89ED-F3BF9BC2CE95Q35788081-D3568BB0-306D-4329-B01D-6C9E53763529Q35843555-D6A1D5C7-3E92-417B-B2B1-6D2A101D3125Q35927466-E137FBC3-DCDB-47B8-BC6D-99D7D57E7C1EQ35949084-788DE8D2-0869-4DF8-96DA-3431267FF48EQ36431196-EF0845C0-E728-4E44-9B79-92C89744AF0DQ36449944-05C5BEAA-9E64-4A57-AAC0-7D5B2329771FQ36451899-03FAD516-8604-4939-B680-09E437E6078FQ36641347-15D1888E-2819-48A9-848F-22E56C67E5BDQ36721024-93533453-D246-4E17-8710-96BD1E6AF94CQ36730633-63169C26-E3E5-4A4B-B91D-695B677054C7Q36951074-96B69E9A-EF1D-4CE4-8704-F59E5AD1DAACQ37029856-4D49099C-DB94-446E-B995-92A286CAC852Q37117167-F765A33F-A509-45B7-BF67-CE785FDEF502Q37229185-3305F490-38EA-4C41-B3AA-C567EAC2DF9BQ37624268-A5A1873B-0BA4-45A4-ADF6-37C21E26F267Q38015746-5A9AAF7D-A899-4479-AFDC-B9B33C8E57BCQ38025824-6F719670-D394-4890-9004-04F91331D4BEQ38246665-F97A989E-CBDC-407F-AC18-84F8CE796095Q38401605-CA7AC083-793A-4B7C-8849-5A3884C494BCQ38686222-8D925355-7819-427B-866F-F2679D0CB593Q38750270-2ED1EA44-50D8-4A94-8F60-478526EA3097
P2860
Cyclophosphamide cardiotoxicity in bone marrow transplantation: a prospective evaluation of new dosing regimens
description
1991 nî lūn-bûn
@nan
1991 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
1991 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
1991年の論文
@ja
1991年論文
@yue
1991年論文
@zh-hant
1991年論文
@zh-hk
1991年論文
@zh-mo
1991年論文
@zh-tw
1991年论文
@wuu
name
Cyclophosphamide cardiotoxicit ...... luation of new dosing regimens
@ast
Cyclophosphamide cardiotoxicit ...... luation of new dosing regimens
@en
Cyclophosphamide cardiotoxicit ...... luation of new dosing regimens
@nl
type
label
Cyclophosphamide cardiotoxicit ...... luation of new dosing regimens
@ast
Cyclophosphamide cardiotoxicit ...... luation of new dosing regimens
@en
Cyclophosphamide cardiotoxicit ...... luation of new dosing regimens
@nl
prefLabel
Cyclophosphamide cardiotoxicit ...... luation of new dosing regimens
@ast
Cyclophosphamide cardiotoxicit ...... luation of new dosing regimens
@en
Cyclophosphamide cardiotoxicit ...... luation of new dosing regimens
@nl
P2093
P1476
Cyclophosphamide cardiotoxicit ...... luation of new dosing regimens
@en
P2093
A C Braverman
M T Plappert
P304
P356
10.1200/JCO.1991.9.7.1215
P407
P577
1991-07-01T00:00:00Z